- Home
- CDNA vs EE Comparison
CDNA vs EE Comparison
Compare CDNA & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- EE
- Stock Information
- Founded
- CDNA 1998
- EE 2003
- Country
- CDNA United States
- EE United States
- Employees
- CDNA N/A
- EE N/A
- Industry
- CDNA Medical Specialities
- EE Oil/Gas Transmission
- Sector
- CDNA Health Care
- EE Utilities
- Exchange
- CDNA Nasdaq
- EE Nasdaq
- Market Cap
- CDNA 712.2M
- EE 786.2M
- IPO Year
- CDNA 2014
- EE 2022
- Fundamental
- Price
- CDNA $13.53
- EE $24.08
- Analyst Decision
- CDNA Buy
- EE Buy
- Analyst Count
- CDNA 8
- EE 7
- Target Price
- CDNA $26.86
- EE $32.86
- AVG Volume (30 Days)
- CDNA 1.5M
- EE 397.0K
- Earning Date
- CDNA 11-03-2025
- EE 11-05-2025
- Dividend Yield
- CDNA N/A
- EE 1.33%
- EPS Growth
- CDNA N/A
- EE 18.98
- EPS
- CDNA 1.00
- EE 1.33
- Revenue
- CDNA $340,826,000.00
- EE $987,637,000.00
- Revenue This Year
- CDNA $13.02
- EE $31.19
- Revenue Next Year
- CDNA $12.85
- EE $25.16
- P/E Ratio
- CDNA $13.56
- EE $18.09
- Revenue Growth
- CDNA 14.72
- EE 9.86
- 52 Week Low
- CDNA $10.96
- EE $18.12
- 52 Week High
- CDNA $32.97
- EE $32.99
- Technical
- Relative Strength Index (RSI)
- CDNA 52.36
- EE 48.55
- Support Level
- CDNA $13.12
- EE $22.86
- Resistance Level
- CDNA $13.80
- EE $23.89
- Average True Range (ATR)
- CDNA 0.67
- EE 0.65
- MACD
- CDNA 0.16
- EE 0.07
- Stochastic Oscillator
- CDNA 63.39
- EE 52.81
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.